Type I Diabetes News and Research

RSS

The skeleton is an endocrine organ

Bones are typically thought of as calcified, inert structures, but researchers at Columbia University Medical Center have now identified a surprising and critically important novel function of the skeleton.

11 Aug 2007

Diet foods may encourage chilhood obesity

Canadian researchers say diet foods may be contributing to the epidemic of childhood obesity because they may inadvertently lead children to overeat.

8 Aug 2007

Parents' depression impacts child's symptoms of depression

A parent's struggle with stress or depression can lower a child's quality of life -- and it could hinder an overweight youngster's attempts to lose weight, too, University of Florida researchers say.

8 Aug 2007

Maternal obesity and birth defects

Mothers of babies born with some structural birth defectsincluding missing limbs, malformed hearts and underdeveloped spinal cordsappear more likely to be obese prior to becoming pregnant than mothers whose children are born without such defects, according to a report in the August issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

7 Aug 2007

Insulin Resistance Syndrome could be key to preventing cardiovascular disease, cancer, diabetes and Alzheimer's

New and important evidence shows that Insulin Resistance Syndrome can lead to elevated risk for cardiovascular disease, breathing and sleep disorders, liver disease, Polycystic Ovarian Syndrome, type 2 diabetes, certain cancers, Alzheimer's Disease and more.

3 Aug 2007

Hostility, anger and depression could increase risk for heart disease in men

Men who are hostile and prone to frequent intense feelings of anger and depression could be harming their immune systems and putting themselves at risk for coronary heart disease as well as related disorders like type 2 diabetes and high blood pressure, a new study finds.

2 Aug 2007

Fiets that fit individuals' health profiles

It could be decades before science can accurately measure the body's systems to determine which foods, in what quantities and combinations, will best combat against disease and illness, experts say.

2 Aug 2007

Breastfeeding from day one could save 1.3 million lives a year

A newly released study has shown that breastfeeding babies from day one reduces the risk of neonatal deaths.

1 Aug 2007

Reducing inflammation plays key role in type 1 diabetes therapy

Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a triple combination therapy consisting of both tolerance-inducing and anti-inflammatory properties is successful in abolishing adverse autoimmunity against insulin-producing cells in a mouse model of Type 1 diabetes.

1 Aug 2007

New risk genes for multiple sclerosis

Two new large-scale genomic studies have honed in on the main genetic pathway associated with multiple sclerosis (MS), while also uncovering new genetic variations in the disease and suggesting a possible link between MS and other autoimmune diseases.

1 Aug 2007

Insulin produced in genetically modified lettuce relieves diabetes in mice

Capsules of insulin produced in genetically modified lettuce could hold the key to restoring the body's ability to produce insulin and help millions of Americans who suffer from insulin-dependent diabetes, according to University of Central Florida biomedical researchers.

1 Aug 2007

Majority of FDA panel votes in favor of Avandia

GlaxoSmithKline has welcomed the nearly unanimous recommendation of an U.S. Food and Drug Administration's (FDA) advisory committee to support Avandia's (rosiglitazone maleate) continued availability to patients in the U.S.

30 Jul 2007

Takeda responds to FDA recommendation on Actos

Following a joint meeting today of the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development (TGRD) underscores its position that ACTOS(R) (pioglitazone HCl) offers a proven safety profile regarding the risk of cardiovascular disease.

30 Jul 2007

Avandia too risky says expert

One of the members of the advisory panel set up to discuss the future of the diabetes pill Avandia says it should be removed from the market because it is too risky and offers no advantage over other alternatives.

30 Jul 2007

Thiazolinediones increase risk of heart failure

A class of drugs commonly used to treat type 2 diabetes may double the risk of heart failure, according to a new analysis by researchers at Wake Forest University School of Medicine and colleagues.

27 Jul 2007

Metformin gets top grade for diabetes

A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.

26 Jul 2007

Obesity spreads within social networks

People wondering about excessive weight gain might look to their relationships with family and friends for one clue, suggests new research reported July 26, 2007, in The New England Journal of Medicine.

26 Jul 2007

Merck appoints David Kelley, M.D., to key role in growing Diabetes and Obesity franchise

Merck & Co., Inc. has announced that David E. Kelley, M.D., has been named vice president, franchise integrator for Diabetes & Obesity. Dr. Kelley joins Merck after 20 years on staff at the University of Pittsburgh, where he most recently served as professor of medicine and director of the Obesity & Nutrition Research Center.

24 Jul 2007

Good diet + exercise = less insulin in the brain and a longer life!

Scientists in the U.S. say reducing the action of insulin in the brain could well be the secret to longevity.

22 Jul 2007

Reducing insulin signaling in the brain can prolong lifespan

One route to a long and healthy life may be establishing the right balance in insulin signaling between the brain and the rest of the body, according to new research from Children's Hospital Boston.

20 Jul 2007